CorMedix Inc. (CRMD)

Name: CorMedix Inc. (CRMD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: CorMedix Inc. (CRMD)

Stock Card

$8.37

$-0.02 (-0.24%)

As on 27-Aug-2026 15:37EDT

Market cap

$639 Mln

Revenue (TTM)

$462 Mln

P/E Ratio

3.8

P/B Ratio

1.4

Div. Yield

0 %

CorMedix (CRMD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 8.28 High: 8.49

52 Week Range

Low: 6.13 High: 14.96

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.5 %
ROCE

-- %
Industry P/E

37.31
EV/EBITDA

2.1
Debt to Equity

0
Book Value

$--
EPS

$2.1
Face value

--
Shares outstanding

77,944,324

10 Years Aggregate

CFO

$-214.34 Mln

EBITDA

$-266.00 Mln

Net Profit

$-265.84 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
CorMedix (CRMD)	-28.0	6.4	1.2	-40.2	27.1	6.7	0.5
BSE Sensex	-9.1	1.1	1.2	-4.8	5.8	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
CorMedix (CRMD)	43.6	114.1	-10.9	-7.3	-38.8	2.1	12.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
CorMedix (CRMD)	8.4	639.1	462.3	187.2	46.4	43.2	3.8	1.4
Amneal Pharmaceuticals Inc Class A (AMRX)	18.0	6,238.0	3,117.6	157.4	14.7	--	37.3	188.9
Axsome Therapeutics (AXSM)	205.8	10,883.2	776.6	-191.6	-17.6	-223.4	--	130.9
BridgeBio Pharma (BBIO)	78.9	15,932.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	117.1	13,215.0	830.8	54.9	3.2	8.1	271.7	18.7
Dr. Reddy's Laboratories - ADR	12.2	10,087.6	332,834.2	33,166.6	11.1	8.9	28.8	2.5
Elanco Animal Health (ELAN)	24.6	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Ligand Pharmaceuticals (LGND)	286.0	5,707.4	290.5	197.2	82.5	19.9	29.6	5.9
Liquidia Technologies Inc (LQDA)	70.4	6,142.1	450.9	138.6	39.1	115.6	49	31.5
Twist Bioscience Corp (TWST)	154.6	9,129.6	431.8	-136.7	-30.8	-30.3	--	20.5

Shareholding Pattern

View Details

About CorMedix (CRMD)

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock... solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey. Read more

CEO & Director

Mr. Joseph Todisco MBA
CEO & Director

Mr. Joseph Todisco MBA
Headquarters

Parsippany, NJ
Website

https://cormedix.com

FAQs for CorMedix (CRMD)

What is the current share price of CorMedix Inc (CRMD) Today?

The share price of CorMedix Inc (CRMD) is $8.37 (NASDAQ) as of 27-Aug-2026 15:37 EDT. CorMedix Inc (CRMD) has given a return of 27.06% in the last 3 years.

What is the current PB & PE ratio of CorMedix Inc (CRMD)?

The P/E ratio of CorMedix Inc (CRMD) is 3.78 times as on 21-Aug-2026, a 90 discount to its peers’ median range of 37.31 times.
The P/B ratio of CorMedix Inc (CRMD) is 1.39 times as on 21-Aug-2026, a 82 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.